Editas Medicine, Inc. (EDIT) › Shareholders' EquityEditas Medicine, Inc. (EDIT) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2013: -$1.76M2014: -$15.29M2015: -$83.11M2016: $134.61M2017: $208.08M2018: $236.16M2019: $262.44M2020: $393.59M2021: $553.64M2022: $360.68M2023: $349.10M2024: $134.27M2025: $27.29M$27.29M2013Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$27.29M-79.7%2024$134.27M-61.5%2023$349.10M-3.2%2022$360.68M-34.9%2021$553.64M+40.7%2020$393.59M+50.0%2019$262.44M+11.1%2018$236.16M+13.5%2017$208.08M+54.6%2016$134.61M+262.0%2015-$83.11M-443.5%2014-$15.29M-767.4%2013-$1.76M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share